Previous 10 |
home / stock / trlpf / trlpf news
Acerus Pharmaceuticals ( OTCPK:TRLPF ): Q1 EPS of -$0.02 More news on: ACERUS PHARMACEUTICALS CORP, Earnings news and commentary, , Read more ...
Acerus Pharmaceuticals Corporation (TRLPF) Q4 2017 Results Earnings Conference Call March 21, 2018, 8:30 am ET Executives Luc Mainville - Interim Chief Executive Officer Ken Yoon - Chief Financial Officer Nathan Bryson - Vice President, Scientific Affairs Analysts Andre Udd...
Acerus Pharmaceuticals ( OTCPK:TRLPF ): Q4 net loss of $2.1M More news on: ACERUS PHARMACEUTICALS CORP, Earnings news and commentary, , Read more ...
Innovus Pharmaceuticals ( OTCQB:INNV ) has entered into an exclusive license and distribution agreement with Acerus Pharmaceuticals ( OTCPK:TRLPF ) for its product UriVarx in Canada. More news on: Innovus Pharmaceuticals, Inc., ACERUS PHARMACEUTICALS CORP, Healthcare stocks news, Rea...
News, Short Squeeze, Breakout and More Instantly...
Trimel Pharmaceuticals Corp. Company Name:
TRLPF Stock Symbol:
OTCMKTS Market:
Play Video After a successful first day to the Bloom Burton & Co. Healthcare Investor Conference (BBHIC), day two proved to be just as exciting for the annual event. Brian Bloom, CEO of Bloom Burto...